[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
create a website
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer. (2023). Beck, Robert J ; Handorf, Elizabeth A ; Geynisman, Daniel M ; Ramamurthy, Chethan ; Correa, Andres.
In: Medical Decision Making.
RePEc:sae:medema:v:43:y:2023:i:7-8:p:949-960.

Full description at Econpapers || Download paper

Cited: 0

Citations received by this document

Cites: 41

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

    This document has not been cited yet.

References

References cited by this document

  1. Aalen O., Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat. 1978;6(3):534–45, 12.
    Paper not yet in RePEc: Add citation now
  2. AccessPharmacy. Drug monographs. Available from: https://accesspharmacy.mhmedical.com/drugs.aspx [Accessed 23 November, 2021].
    Paper not yet in RePEc: Add citation now
  3. Bayoumi AM, Brown AD, Garber AM., Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst. 2000;92(21):1731–9.
    Paper not yet in RePEc: Add citation now
  4. Box M., A new method of constrained optimization and a comparison with other methods. Comput J. 1965;8(1):42–52.
    Paper not yet in RePEc: Add citation now

  5. Brennan A, Chick SE, Davies R., A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006;15(12):1295–310.

  6. Centers for Medicare & Medicaid Services. Medicare physician fee schedule look-up tool. 2021. Available from: https://www.cms.gov/medicare/physician-fee-schedule/search [Accessed 23 November, 2021].
    Paper not yet in RePEc: Add citation now
  7. Chi KN, Protheroe A, Rodríguez-Antolín A, , et al, . Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. Lancet Oncol. 2018;19(2):194–206.
    Paper not yet in RePEc: Add citation now
  8. Collett D., Modelling Survival Data in Medical Research. New York: CRC Press; 2015.
    Paper not yet in RePEc: Add citation now
  9. Davis ID, Martin AJ, Stockler MR, , et al, . Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med. 2019;381(2):121–31.
    Paper not yet in RePEc: Add citation now
  10. Diaby V, Adunlin G, Ali AA, , et al, . Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat. 2016;160(1):187–96.
    Paper not yet in RePEc: Add citation now
  11. Diaby V, Alqhtani H, van Boemmel-Wegmann S, , et al, . A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2020;49:141–8.
    Paper not yet in RePEc: Add citation now
  12. Eisenberger M, Hardy-Bessard A-C, Kim CS, , et al, . Phase III study comparing a reduced dose of cabazitaxel (20 mg/m2) and the currently approved dose (25 mg/m2) in postdocetaxel patients with metastatic castration-resistant prostate cancer—PROSELICA. J Clin Oncol. 2017;35(28):3198–206. Amazon. Amazon pharmacy. Available from: www.amazon.com.
    Paper not yet in RePEc: Add citation now
  13. Elting LS, Cooksley C, Bekele BN, , et al, . Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006;106(11):2452–8.
    Paper not yet in RePEc: Add citation now
  14. Fizazi K, Foulon S, Carles J, , et al, . Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. Lancet. 2022;399(10336):1695–707.
    Paper not yet in RePEc: Add citation now
  15. Fizazi K, Tran N, Fein L, , et al, . Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med. 2017;377(4):352–60.
    Paper not yet in RePEc: Add citation now
  16. Freedman-Cass D, Berardi R, Shead D., NCCN guidelines version 3.2022 prostate cancer. 2022. https://isotopia-global.com/wp-content/uploads/2022/04/NCCN-guidlines-prostate-cancer-2022.pdf.
    Paper not yet in RePEc: Add citation now
  17. Gibson EJ, Begum N, Koblbauer I, , et al, . Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma. J Med Econ. 2019;22(6):531–44.
    Paper not yet in RePEc: Add citation now

  18. Graves J, Garbett S, Zhou Z, Schildcrout JS, Peterson J., Comparison of decision modeling approaches for health technology and policy evaluation. Med Decis Making. 2021;41(4):453–64.

  19. Guyot P, Ades AE, Ouwens MJNM, Welton NJ., Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12(1):9.
    Paper not yet in RePEc: Add citation now
  20. Hird AE, Magee DE, Cheung DC, Matta R, Kulkarni GS, Nam RK., Abiraterone vs., docetaxel for metastatic hormone-sensitive prostate cancer: a microsimulation model. Can Urol Assoc J. 2020;14(9):E418–27.
    Paper not yet in RePEc: Add citation now
  21. Hirsh V, Singh J., Optimal sequencing strategies in the treatment of EGFR mutation–positive non–small cell lung cancer: clinical benefits and cost-effectiveness. Am J Health Syst Pharm. 2020;77(18):1466–76.
    Paper not yet in RePEc: Add citation now
  22. Kassem L, Shohdy KS, Abdel-Rahman O., Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy. Curr Med Res Opin. 2018;34(5):903–10.
    Paper not yet in RePEc: Add citation now
  23. Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR., Cost-effectiveness of immune checkpoint inhibition in BRAF wild-type advanced melanoma. J Clin Oncol. 2017;35(11):1194.
    Paper not yet in RePEc: Add citation now

  24. Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MM, Pechlivanoglou P., Microsimulation modeling for health decision sciences using R: a tutorial. Med Decis Making. 2018;38(3):400–22.

  25. Lyman GH, Lalla A, Barron RL, Dubois RW., Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States. Clin Ther. 2009;31(5):1092–104.
    Paper not yet in RePEc: Add citation now
  26. Morgans AK, Chen Y-H, Sweeney CJ, , et al, . Quality of life during treatment with chemohormonal therapy: analysis of E3805 chemohormonal androgen ablation randomized trial in prostate cancer. J Clin Oncol. 2018;36(11):1088.
    Paper not yet in RePEc: Add citation now
  27. Nelder JA, Mead R., A simplex method for function minimization. Comput J. 1965;7(4):308–13.
    Paper not yet in RePEc: Add citation now
  28. Petrylak DP, Vogelzang NJ, Budnik N, , et al, . Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Oncol. 2015;16(4):417–25.
    Paper not yet in RePEc: Add citation now
  29. Pollard ME, Moskowitz AJ, Diefenbach MA, Hall SJ., Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer. Asian J Urol. 2017;4(1):37–43.
    Paper not yet in RePEc: Add citation now
  30. Ramamurthy C, Handorf EA, Correa AF, Beck JR, Geynisman DM., Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer. Urol Oncol. 2019;37(10):688–95.
    Paper not yet in RePEc: Add citation now
  31. Riesco-Martínez MC, Berry SR, Ko Y-J, , et al, . Cost-effectiveness analysis of different sequences of the use of epidermal growth factor receptor inhibitors for wild-type KRAS unresectable metastatic colorectal cancer. J Oncol Pract. 2016;12(6):e710–23.
    Paper not yet in RePEc: Add citation now
  32. Ryan CJ, Smith MR, de Bono JS, , et al, . Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2012;368(2):138–48.
    Paper not yet in RePEc: Add citation now
  33. Schofield D, Zeppel M, Tan O, Lymer S, Cunich MM, Shrestha RN., A brief, global history of microsimulation models in health: past applications, lessons learned and future directions. Int J Microsimulation. 2018;11(1):97–142.
    Paper not yet in RePEc: Add citation now
  34. Shore N, Heidenreich A, Saad F., Predicting response and recognizing resistance: improving outcomes in patients with castration-resistant prostate cancer. Urology. 2017;109:6–18.
    Paper not yet in RePEc: Add citation now
  35. Siebert U, Alagoz O, Bayoumi AM, , et al, . State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3. Med Decis Making. 2012;32(5):690–700.
    Paper not yet in RePEc: Add citation now
  36. Statistics USBoL. Consumer price index for all urban consumers: medical care in U.S. city average [CPIMEDSL] FRED, Federal Reserve Bank of St. Louis, 2022. Available from: https://fred.stlouisfed.org/series/CPIMEDSL.
    Paper not yet in RePEc: Add citation now
  37. Sweeney CJ, Chen YH, Carducci M, , et al, . Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373(8):737–46.
    Paper not yet in RePEc: Add citation now
  38. Wang W, Ma Y, Huang Y, Chen H., Generalizability analysis for clinical trials: a simulation study. Stat Med. 2017;36(10):1523–31.
    Paper not yet in RePEc: Add citation now
  39. Younis T, Rayson D, Skedgel C., The cost–utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer. Curr Oncol. 2011;18(6):288–96. Social Security Administration. Actuarial life table. Available from: https://www.ssa.gov/oact/STATS/table4c6.html. Gray B, . cmprsk: subdistribution analysis of competing risks. 2.2-10 ed2020. https://cran.r-project.org/web/packages/cmprsk/index.html. Bihorel SB, Michael, . neldermead: R port of the ‘scilab’ neldermead module. 1.0-11 ed2010. https://cran.r-project.org/web/packages/neldermead/index.html.
    Paper not yet in RePEc: Add citation now
  40. Zhang P-F, Xie D, Li Q., Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance. BMC Cancer. 2021;21(1):35.
    Paper not yet in RePEc: Add citation now
  41. Zhong L, Pon V, Srinivas S, , et al, . Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis. PLoS One. 2013;8(5):e64275.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions. (2021). Wilkinson, Clare ; Sutton, Alex J ; Hughes, Dyfrig ; Lewis, Ruth A.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00980-w.

    Full description at Econpapers || Download paper

  2. A Framework for Developing a Model Structure of Budget Impact Analysis for New Health Care Interventions in Jordan. (2021). Bakir, Amir ; Massad, Eman Mohammad.
    In: International Journal of Economics and Financial Issues.
    RePEc:eco:journ1:2021-01-13.

    Full description at Econpapers || Download paper

  3. .

    Full description at Econpapers || Download paper

  4. .

    Full description at Econpapers || Download paper

  5. .

    Full description at Econpapers || Download paper

  6. .

    Full description at Econpapers || Download paper

  7. .

    Full description at Econpapers || Download paper

  8. A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers. (2020). Levell, N J ; McManus, Emma ; Layer, Ashley.
    In: PharmacoEconomics - Open.
    RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0148-x.

    Full description at Econpapers || Download paper

  9. Modelling the impact of physical activity on public health: A review and critique. (2020). Meads, David ; Candio, Paolo ; Bojke, Laura ; Hill, Andrew J.
    In: Health Policy.
    RePEc:eee:hepoli:v:124:y:2020:i:10:p:1155-1164.

    Full description at Econpapers || Download paper

  10. Spatial Transmission Models: A Taxonomy and Framework. (2019). Robertson, Duncan A.
    In: Risk Analysis.
    RePEc:wly:riskan:v:39:y:2019:i:1:p:225-243.

    Full description at Econpapers || Download paper

  11. Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review. (2019). Payne, Katherine ; Newman, William G ; Wright, Stuart J.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:37:y:2019:i:8:d:10.1007_s40273-019-00801-9.

    Full description at Econpapers || Download paper

  12. Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany. (2019). Schneider, Udo ; Holle, Rolf ; Laxy, Michael ; Kahm, Katharina.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0699-1.

    Full description at Econpapers || Download paper

  13. A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments. (2019). Shields, Gemma E ; Cranmer, Holly L ; Bullement, Ash.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:17:y:2019:i:6:d:10.1007_s40258-019-00513-3.

    Full description at Econpapers || Download paper

  14. Smoking Cessation: A Comparison of Two Model Structures. (2018). Taylor, Matthew ; Owen, Lesley ; Filby, Alex ; Pennington, Becky.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0657-y.

    Full description at Econpapers || Download paper

  15. The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal. (2018). Levell, Nick ; Sach, Tracey ; McManus, Emma.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:36:y:2018:i:1:d:10.1007_s40273-017-0564-7.

    Full description at Econpapers || Download paper

  16. Model Structuring for Economic Evaluations of New Health Technologies. (2018). Karnon, Jonathan ; Bojke, Laura ; Ali, Hossein Haji.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0693-7.

    Full description at Econpapers || Download paper

  17. Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim .
    In: PharmacoEconomics - Open.
    RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2.

    Full description at Econpapers || Download paper

  18. Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews. (2017). Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen ; Salleh, Syed ; Booth, Andrew.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0523-3.

    Full description at Econpapers || Download paper

  19. Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling. (2017). Sharples, Linda ; Welton, Nicky ; Jackson, Chris ; Thom, Howard.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0501-9.

    Full description at Econpapers || Download paper

  20. Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis. (2017). Shih, Ya-Chen ; Olson, Melvin ; Lecomte, Pascal ; Goto, Daisuke ; Mullins, Daniel C ; Park, Yujin ; Udeze, Chukwukadibia .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0505-5.

    Full description at Econpapers || Download paper

  21. Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care. (2017). Brazier, John ; Chevrou-Severac, Helene ; Mukuria, Clara ; Peasgood, Tessa ; Ara, Roberta ; Hout, Ben ; Young, Tracey ; Paisley, Suzy ; Azzabi-Zouraq, Ismail ; Rowen, Donna.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0543-z.

    Full description at Econpapers || Download paper

  22. An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting. (2017). Scuffham, Paul ; Standfield, L B ; Comans, T A.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:18:y:2017:i:1:d:10.1007_s10198-015-0756-z.

    Full description at Econpapers || Download paper

  23. Enabling better management of patients: discrete event simulation combined with the STAR approach. (2017). Demir, Eren ; Southern, David .
    In: Journal of the Operational Research Society.
    RePEc:pal:jorsoc:v:68:y:2017:i:5:d:10.1057_s41274-016-0029-y.

    Full description at Econpapers || Download paper

  24. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease. (2016). Santos, Rodrigo Dos ; Dossantos, Rodrigo ; Ozen, Asli ; Hernandez, Luis ; Getsios, Denis .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0392-1.

    Full description at Econpapers || Download paper

  25. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. (2016). Wasem, Juergen ; Perleth, Matthias ; Greiner, Wolfgang ; Levy-Bruhl, Daniel ; Hutubessy, Raymond ; Salo, Heini ; Bruggenjurgen, Bernd ; Hanquet, Germaine ; Postma, Maarten ; Wichmann, Ole ; Damm, Oliver ; Kuhlmann, Alexander ; Ultsch, Bernhard ; Beutels, Philippe ; Siebert, Uwe ; Bilcke, Joke ; Gerber-Grote, Andreas ; Kries, Rudiger ; Jit, Mark ; Knol, Mirjam .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:3:p:227-244.

    Full description at Econpapers || Download

  26. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. (2016). Wasem, Juergen ; Perleth, Matthias ; Bruggenjurgen, Bernd ; Knol, Mirjam ; Bilcke, Joke ; Kuhlmann, Alexander ; Hutubessy, Raymond ; Levy-Bruhl, Daniel ; Salo, Heini ; Siebert, Uwe ; Postma, Maarten ; Greiner, Wolfgang ; Kries, Rudiger ; Beutels, Philippe ; Jit, Mark ; Damm, Oliver ; Wichmann, Ole ; Ultsch, Bernhard ; Hanquet, Germaine ; Gerber-Grote, Andreas.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:3:d:10.1007_s40273-015-0335-2.

    Full description at Econpapers<

  27. Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastr. (2016). Card, Timothy ; West, Joe ; Canavan, Caroline .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:2:p:181-194.

    Full description at Econpapers || Download paper

  28. Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastr. (2016). Canavan, Caroline ; West, Joe ; Card, Timothy .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0339-y.

    Full description at Econpapers || Download paper

  29. Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations. (2016). Payne, Katherine ; Rogowski, Wolf H ; Thompson, Alexander ; Iglesias, Cynthia P.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0425-9.

    Full description at Econpapers || Download paper

  30. A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. (2016). , ; Prinzen, F ; Tomini, F.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:17:y:2016:i:9:d:10.1007_s10198-015-0752-3.

    Full description at Econpapers || Download paper

  31. Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Gordon, James ; Griebsch, Ingolf ; Xu, Peng.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:32:y:2014:i:10:p:981-993.

    Full description at Econpapers || Download paper

  32. Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model. (2014). Knottnerus, J. ; Ramos, G. ; Dompeling, Edward ; Asselt, Antoinette ; Maas, Tanja ; Kuiper, Sandra ; Schayck, Onno ; Severens, Johan .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:15:y:2014:i:8:p:869-883.

    Full description at Econpapers || Download paper

  33. A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder. (2014). Mohiuddin, Syed .
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:12:y:2014:i:4:p:359-372.

    Full description at Econpapers || Download paper

  34. Combining discrete-event simulation and system dynamics in a healthcare setting: A composite model for Chlamydia infection. (2014). Viana, J. ; Harindra, V. ; Brailsford, S. C. ; Harper, P. R..
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:237:y:2014:i:1:p:196-206.

    Full description at Econpapers || Download paper

  35. Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling. (2013). Gray, Alastair ; Baldwin, Michael ; Mungapen, Laura ; Price, David ; Asukai, Yumi ; Fonseca, Tiago.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:31:y:2013:i:2:p:151-161.

    Full description at Econpapers || Download paper

  36. Improving Health Outcomes Through Better Capacity Allocation in a Community-Based Chronic Care Model. (2013). Deo, Sarang ; Jiang, Tingting ; Samuelson, Stephen ; Smilowitz, Karen ; Iravani, Seyed .
    In: Operations Research.
    RePEc:inm:oropre:v:61:y:2013:i:6:p:1277-1294.

    Full description at Econpapers || Download paper

  37. Economic implications of poor access to antenatal care in rural and remote Western Australian Aboriginal communities: An individual sampling model of pregnancy. (2013). Larson, Ann ; Mueller, Ute A. ; Simmer, Karen ; Newnham, John P. ; Cannon, Jeffrey W. ; Hornbuckle, Janet ; Doherty, Dorota A..
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:226:y:2013:i:2:p:313-324.

    Full description at Econpapers || Download paper

  38. Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model. (2012). Sin, Don ; McManus, Bruce ; Fitzgerald, Mark J ; Sadatsafavi, Mohsen ; Lynd, Larry D ; Marra, Carlo A ; Najafzadeh, Mehdi.
    In: PLOS ONE.
    RePEc:plo:pone00:0046746.

    Full description at Econpapers || Download paper

  39. Resource planning for ambulance services in mass casualty incidents: a DES-based policy model. (2012). Schaffhauser-Linzatti, Michaela ; Rauner, Marion ; Niessner, Helmut.
    In: Health Care Management Science.
    RePEc:kap:hcarem:v:15:y:2012:i:3:p:254-269.

    Full description at Econpapers || Download paper

  40. What happens to value of information measures as the number of decision options increases?. (2011). Barton, Pelham.
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:7:p:853-863.

    Full description at Econpapers || Download paper

  41. Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. (2010). Lugner, Anna K. ; Mylius, Sido D. ; Wallinga, Jacco.
    In: Health Economics.
    RePEc:wly:hlthec:v:19:y:2010:i:5:p:518-531.

    Full description at Econpapers || Download paper

  42. Hospital management games: a taxonomy and extensive review. (2010). Schwarz, Sigrun ; Rauner, Marion ; Kraus, Markus.
    In: Central European Journal of Operations Research.
    RePEc:spr:cejnor:v:18:y:2010:i:4:p:567-591.

    Full description at Econpapers || Download paper

  43. Reducing access times for an endoscopy department by an iterative combination of computer simulation and Linear Programming. (2010). Joustra, P. ; Fockens, P. ; Wit, J. ; Overbeek, B. ; Struben, V. ; Elkhuizen, S..
    In: Health Care Management Science.
    RePEc:kap:hcarem:v:13:y:2010:i:1:p:17-26.

    Full description at Econpapers || Download paper

  44. Dynamic Policy Modeling for Chronic Diseases: Metaheuristic-Based Identification of Pareto-Optimal Screening Strategies. (2010). Wagner, Joachim ; Heidenberger, Kurt ; Rauner, Marion S ; Gutjahr, Walter J ; Pasia, Joseph .
    In: Operations Research.
    RePEc:inm:oropre:v:58:y:2010:i:5:p:1269-1286.

    Full description at Econpapers || Download paper

  45. Simulation sample sizes for Monte Carlo partial EVPI calculations. (2010). Brennan, Alan ; Tappenden, Paul ; Chilcott, Jim ; Oakley, Jeremy E..
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:3:p:468-477.

    Full description at Econpapers || Download paper

  46. Simulation or cohort models? Continuous time simulation and discretized Markov models to estimate cost-effectiveness. (2010). Soares, Marta ; L Canto e Castro, .
    In: Working Papers.
    RePEc:chy:respap:56cherp.

    Full description at Econpapers || Download paper

  47. The cost-effectiveness of surgical instrument management policies to reduce the risk of vCJD transmission to humans. (2009). Stevenson, M D ; Chalkidou, K ; Chick, S E ; Oakley, J E.
    In: Journal of the Operational Research Society.
    RePEc:pal:jorsoc:v:60:y:2009:i:4:d:10.1057_palgrave.jors.2602580.

    Full description at Econpapers || Download paper

  48. A tutorial on discrete-event simulation for health policy design and decision making: Optimizing pediatric ultrasound screening for hip dysplasia as an illustration. (2009). Buskens, Erik ; Sakkers, Ralph J. B., ; Ramwadhdoebe, Sabrina ; Stahl, James E..
    In: Health Policy.
    RePEc:eee:hepoli:v:93:y:2009:i:2-3:p:143-150.

    Full description at Econpapers || Download paper

  49. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. (2007). Madan, Jason ; Stevenson, Matt ; O'Hagan, Anthony.
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:10:p:1009-1023:a.

    Full description at Econpapers || Download paper

  50. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. (2007). O'Hagan, Anthony ; Stevenson, Matt ; Madan, Jason .
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:10:p:1009-1023.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2024-12-26 16:47:16 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.